摘要
ObjectiveFerroptosis is an iron-dependent type of regulated cell death triggered by the toxic buildup of lipid peroxides on cell membranes. Nonetheless, the implication of ferroptosis in triple-negative breast cancer (TNBC), which is the most aggressive subtype of breast carcinoma, remains unexplored. MethodsThree TNBC cohorts-TCGA-TNBC, GSE58812, and METABRIC-were adopted. Consensus molecular subtyping on prognostic ferroptosis-related genes was implemented across TNBC. Ferroptosis classification-relevant genes were selected through weighted co-expression network analysis (WGCNA), and a ferroptosis-relevant scoring system was proposed through the LASSO approach. Prognostic and immunological traits, transcriptional and post-transcriptional modulation, therapeutic response, and prediction of potential small-molecule agents were conducted. ResultsThree disparate ferroptosis patterns were identified across TNBC, with prognostic and immunological traits in each pattern. The ferroptosis-relevant scoring system was proposed, with poorer overall survival in high-risk patients. This risk score was strongly linked to transcriptional and post-transcriptional mechanisms. The high-risk group had a higher response to anti-PD-1 blockade or sunitinib, and the low-risk group had higher sensitivity to cisplatin. High relationships of risk score with immunological features were observed across pan-cancer. Two Cancer Therapeutics Response Portal (CTRP)-derived agents (SNX-2112 and brefeldin A) and PRISM-derived agents (MEK162, PD-0325901, PD-318088, Ro-4987655, and SAR131675) were predicted, which were intended for high-risk patients. ConclusionAltogether, our findings unveil prognostic, immunological, and pharmacogenomic features of ferroptosis in TNBC, highlighting the potential clinical utility of ferroptosis in TNBC therapy.
学科与关键词
- Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancerWang, Yaru; Sun, Yue; Wang, Feiran; Wang, Hongyi; Hu, Jing*Biomedicine and Pharmacotherapy, 2023, 169: 115866.
- Combination Analysis of Ferroptosis and Immune Status Predicts Patients Survival in Breast Invasive Ductal CarcinomaYang, Yang; Luo, Dankun; Gao, Wenqi; Wang, Qiang; Yao, Wenchao; Xue, Dongbo*; Ma, Biao*Biomolecules, 2023, 13(1): 147.
- Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progressionSui, Shiyao; Xu, Shouping*; Pang, Da*Pharmacology and Therapeutics, 2022, 232: 107992.被引 51
